{"jsonapi":{"version":"1.0"},"data":{"type":"recalls","id":"4f351186e0de78e63fa1231a4ffc56b66d55ccfe13ff816306c46b76516fffb2","attributes":{"feedName":"fda","feedSource":"fda","title":"Teva Pharmaceuticals USA, Inc. Expands Voluntary Nationwide Recall of Losartan Potassium to 50 mg and 100 mg Tablets USP, Sold Exclusively to Golden State Medical Supply, Inc.","description":"This expanded recall includes six (6) lots of bulk losartan potassium USP Tablets (two lots of 50 mg strength and four lots of 100 mg strength) due to the detection of an impurity â€“ N-Nitroso-N-methyl-4-aminobutyric acid (NMBA)","link":"https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/teva-pharmaceuticals-usa-inc-expands-voluntary-nationwide-recall-losartan-potassium-50-mg-and-100-mg","publicationDate":"2019-06-10T04:00:00.000Z","state":"sent","affected":[],"allergens":[],"audience":["consumers"],"categories":["drugs"],"contaminants":["other"],"distribution":["CA"],"risk":"none","token":"5d9e68d68b079e002a251d1b"}}}